Crowley MM - Search Results

1

Pharmaceutical applications of hot-melt extrusion: part I.

Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, McGinity JW, Martin C. Crowley MM, et al. Drug Dev Ind Pharm. 2007 Sep;33(9):909-26. doi: 10.1080/03639040701498759. Drug Dev Ind Pharm. 2007. PMID: 17891577 Review.

2

Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion.

Crowley MM, Zhang F, Koleng JJ, McGinity JW. Crowley MM, et al. Biomaterials. 2002 Nov;23(21):4241-8. doi: 10.1016/s0142-9612(02)00187-4. Biomaterials. 2002. PMID: 12194527

3

Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion.

Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M, Kucera S, McGinity JW. Crowley MM, et al. Int J Pharm. 2004 Jan 28;269(2):509-22. doi: 10.1016/j.ijpharm.2003.09.037. Int J Pharm. 2004. PMID: 14706261

4

The use of near-infrared spectroscopy for the quantitation of a drug in hot-melt extruded films.

Tumuluri SV, Prodduturi S, Crowley MM, Stodghill SP, McGinity JW, Repka MA, Avery BA. Tumuluri SV, et al. Among authors: crowley mm. Drug Dev Ind Pharm. 2004 May;30(5):505-11. doi: 10.1081/ddc-120037481. Drug Dev Ind Pharm. 2004. PMID: 15244086

5

Pharmaceutical applications of hot-melt extrusion: Part II.

Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F, Martin C, McGinity JW. Repka MA, et al. Among authors: crowley mm. Drug Dev Ind Pharm. 2007 Oct;33(10):1043-57. doi: 10.1080/03639040701525627. Drug Dev Ind Pharm. 2007. PMID: 17963112 Review.

6

Physicochemical properties of film-coated melt-extruded pellets.

Young CR, Crowley M, Dietzsch C, McGinity JW. Young CR, et al. J Microencapsul. 2007 Feb;24(1):57-71. doi: 10.1080/02652040601058483. J Microencapsul. 2007. PMID: 17438942

7

The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films.

Crowley MM, Fredersdorf A, Schroeder B, Kucera S, Prodduturi S, Repka MA, McGinity JW. Crowley MM, et al. Eur J Pharm Sci. 2004 Aug;22(5):409-18. doi: 10.1016/j.ejps.2004.04.005. Eur J Pharm Sci. 2004. PMID: 15265510

8

Review of the TAIFUN multidose dry powder inhaler technology.

Overhoff KA, Clayborough R, Crowley M. Overhoff KA, et al. Drug Dev Ind Pharm. 2008 Sep;34(9):960-5. doi: 10.1080/03639040802154897. Drug Dev Ind Pharm. 2008. PMID: 18686086 Review.

9

Abuse-deterrent properties of REMOXY® ER, a high-viscosity extended-release oxycodone formulation.

Kucera SA, Zamloot MS, Crowley MM, Burns LH, Friedmann N, Barbier R. Kucera SA, et al. Among authors: crowley mm. J Opioid Manag. 2018 Nov/Dec;14(6):429-436. doi: 10.5055/jom.2018.0475. J Opioid Manag. 2018. PMID: 30629279

10

Athlete doping confrontation efficacy and confrontation likelihood.

Harris TS, Crowley MM, Heller HM. Harris TS, et al. Among authors: crowley mm. Psychol Sport Exerc. 2023 Mar;65:102370. doi: 10.1016/j.psychsport.2022.102370. Epub 2022 Dec 21. Psychol Sport Exerc. 2023. PMID: 37665842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters